Microangiopathy-related cerebral damage and angiotensinogen gene: from epidemiology to biology

H Schmidt1, F Fazekas, R Schmidt

  • 1Institute of Medical Biochemistry and Medical Molecular Biology, Karl-Franzens University, Graz, Austria. helena.schmidt@kfunigraz.ac.at

Journal of Neural Transmission. Supplementum
|November 29, 2002
PubMed

Insights

Microangiopathy-related cerebral damage (MARCD) is linked to specific gene variations in the renin-angiotensin system (RAS). The B haplotype of the angiotensinogen gene promoter was significantly associated with MARCD, independent of hypertension.

Area of Science:

  • Genetics
  • Neurology
  • Cardiovascular Science

Background:

  • Microangiopathy-related cerebral damage (MARCD) is prevalent in the elderly, causing cognitive and gait issues.
  • Arterial hypertension and age are established risk factors for MARCD.
  • Genes regulating blood pressure, particularly the renin-angiotensin system (RAS), are potential candidates for MARCD susceptibility.

Purpose of the Study:

  • To investigate the association between angiotensinogen (AGT) gene promoter haplotypes and MARCD.
  • To explore the role of local RAS activity in the development of MARCD.

Main Methods:

  • Genotyping of four common AGT promoter mutations to define five haplotypes (A, B, C, D, E).
  • Association study of AGT haplotypes with MARCD in the Austrian Stroke Prevention Study cohort.
  • In vitro investigation of AGT promoter activity in astrocytes.

Main Results:

  • The B haplotype of the AGT promoter showed a significant association with MARCD (p = 0.005).
  • This association remained significant even after accounting for hypertension, suggesting a direct genetic link.
  • Promoter activity assays indicated that AGT gene expression can be modulated by specific haplotypes.

Conclusions:

  • Specific haplotypes of the angiotensinogen gene promoter are associated with microangiopathy-related cerebral damage.
  • The findings suggest a potential role for the local renin-angiotensin system in the pathogenesis of MARCD, independent of systemic blood pressure regulation.
  • Genetic variations in the AGT gene may contribute to cerebral microvascular disease susceptibility.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...